Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?

BACKGROUND: Type 2 diabetes is a syndrome defined by hyperglycaemia that is the result of various degrees of pancreatic β-cell failure and reduced insulin sensitivity. Although diabetes can be caused by multiple metabolic dysfunctions, most patients are defined as having either type 1 or type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Veelen, Anna, Erazo-Tapia, Edmundo, Oscarsson, Jan, Schrauwen, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085543/
https://www.ncbi.nlm.nih.gov/pubmed/33387681
http://dx.doi.org/10.1016/j.molmet.2020.101158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085543/
https://www.ncbi.nlm.nih.gov/pubmed/33387681
http://dx.doi.org/10.1016/j.molmet.2020.101158

Ejemplares similares